Zoetis Inc. (ZTS)
NYSE: ZTS · Pharmaceutical Preparations · Parsippany, NJ · filing with the SEC since 2012
Grade6.7
◀ Past 8.4● Present 7.0▶ Future 4.5
Who owns Zoetis Inc.
As filed with the SECHolders of 5% or more
3
Blackrock, Inc. holds 9% of Class A Stock, as its SCHEDULE 13G/A filed Jul 30, 2026 says.
Directors and officers
25
report now, of 47 people on the record since 2013. Their holdings as a group are not read here.
Institutions as a whole
n/a
The record does not read the share held by managers that file Form 13F, so none is printed and no split of the rest is estimated. What it holds is the 3 named at left.
Holders of 5% or moreshare of the class, as filed
Blackrock, Inc.
SCHEDULE 13G/A · filed Jul 30, 2026 · Class A Stock
Vanguard Capital Management
SCHEDULE 13G · filed Apr 30, 2026 · Common Stock
Vanguard Portfolio Management
SCHEDULE 13G · filed Apr 29, 2026 · Common Stock
The Vanguard Group
SCHEDULE 13G/A · filed Mar 27, 2026 · Common Stock · reported falling below 5%, from 10.8% in Jan 7, 2026
What ZTS reports owning in othersstakes of 5% or more, and other ties
111 subsidiaries in 54 countries, from the list filed with the 10-K filed Feb 12, 2026.
Insider tradesForm 4
2sales
3purchases
2sales on a scheduled plan
1people selling
$2.5Msold, in dollars
$900,000bought, in dollars
Open-market trades on Form 4 from Nov 3, 2025 to Nov 3, 2026. A scheduled plan is a selling program set in advance under SEC rule 10b5-1. The trades are listed as filed and do not feed the grade.
By calendar yearSoldBought
2026 runs to Nov 3, 2026. Dollars as filed, summed by the transaction date.
People who traded in the window4 of 47 on the roster
| Person | Role as filed | Sales | Sold | On a plan | Buys | Bought |
|---|---|---|---|---|---|---|
| Peck Kristin C | Chief Executive Officer | 2 | $2.5M | 2 | 0 | $0 |
| Damelio Frank A | director | 0 | $0 | 0 | 1 | $500,000 |
| Mccallister Michael B | director | 0 | $0 | 0 | 1 | $200,000 |
| Bisaro Paul | director | 0 | $0 | 0 | 1 | $200,000 |